Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

TSPYL2 regulated by miR-301a-3p contributes to impaired decidualization in polycystic ovary syndrome.

Created on 13 Nov 2026

Authors

Jiali Ruan, Ayako Muraoka, Akira Yokoi, Bayasula, Kosuke Yoshida, Takehiko Takeda, Tomomi Seki, Natsuki Miyake, Reina Sonehara, Tomoko Nakamura, Satoko Osuka, Hiroaki Kajiyama

Published in

Scientific reports. Volume 16. Pages 36650. Epub Aug 05, 2026.

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders associated with female infertility. Increasing evidence suggests that impaired endometrial receptivity, in addition to ovulatory dysfunction, may contribute to infertility in women with PCOS. However, the molecular mechanisms underlying defective decidualization in PCOS remain poorly understood. We observed impaired decidualization in both a prenatally androgenized mouse model and primary endometrial stromal cells from patients with PCOS. Testis-specific Y-encoded-like protein 2 (TSPYL2) displayed aberrant expression dynamics in PCOS, with elevated expression in the proliferative phase but insufficient induction during decidualization. Silencing TSPYL2 impaired decidualization and reduced implantation capacity in vitro and in vivo. Transcriptomic analysis further showed that TSPYL2 knockdown was associated with increased cell-cycle-associated signatures and reduced expression of hormone-responsive, decidualization- and endometrial receptivity-associated genes. Serum miR-301a-3p was upregulated during the secretory phase in PCOS and directly targeted the 3' untranslated region of TSPYL2, suppressing its expression. Our findings suggest that elevated miR-301a-3p may impair decidualization by targeting TSPYL2, thereby contributing to defective endometrial function in PCOS.
The online version contains supplementary material available at https://doi.org/10.1038/s41598-026-65152-w.

PMID:
43019204
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement